As the presidential election draws ever nearer, the debate over how to address the rising cost of prescription drugs and provide healthcare coverage for all continues to rage. President Trump plans to unveil his healthcare plan soon. Governor Abbott of Texas has signed into law a measure to prevent ‘surprise billing.’ This and more are ...

This week’s Innovation Partners BioBlog offers unique perspectives on the issues facing the healthcare industry today. Some CEOs, for example, believe that a “Medicare for all” type of health insurance system would improve the economy by decoupling health insurance from the cost of hiring workers. Other perspectives include an interview with FDA Director Janet Woodcock, ...

The annual ASCO Meeting, held in Chicago, May 31-June 4, 2019, explored many issues related to oncology. Exciting developments in the field of early detection include Grail’s liquid biopsy test and data showing that Medicaid expansion helped detect more cases of ovarian cancer earlier, potentially saving lives. New treatments for pancreatic cancer cut progression risk ...

This week’s Innovation Partners BioBlog looks at top stories from the world of pharmaceutical and healthcare news. Elderly people who survive the three most common types of cancer are at an increase for brain metastasis, according to a new report. The Trump Administration continues to push for the repeal of the Affordable Care Act. And ...

Discussions in the news this week circle around CAR-T payments, PBM rebates, and whether or not the Trump Administration will continue voluntary payment models. A new blockchain healthcare initiative demonstrates how the Internet of Things (IoT), blockchain, and healthcare can work together for improved tracking and outcomes. And the ESMO Breast Cancer Congress is underway ...

Activity at the state and federal level this week is heating up in the fight against higher drug and healthcare costs. PBMs testified before federal lawmakers, who seemed uncertain of their role in the industry. The Montana Senate delayed the Medicaid bill, and Pennsylvania’s Attorney General filed a petition to attempt to force UPMC to ...

Debates continue in the government’s quest to push down the cost of prescription drugs as two new treatments, one for postpartum depression and another for depression hit the market with high price tags. Others are tackling “surprise” medical bills, but the ramifications are problematic. These topics and more in this week’s Innovation Partners BioBlog. It ...

Nationwide, Congress, insurers, and others continue to wrestle with the costs of healthcare. What is good for some consumers may be bad for others, and a bipartisan coalition is asking the Trump Administration to consider this while they work on legislation regarding drug pricing. Other actions are trying to reduce ‘surprise’ bills from providers, while ...

In this week's Innovation Partners BioBlog, we look at how United Health and its pharmacy benefits management arm, OptumRX, are looking to pass rebates to new employer customers to deflect criticism from many fronts. Scott Gottlieb, the FDA Chief, announced he is stepping down, possibly as early as April. Hospitals are struggling to get paid ...

That’s the subject of this week’s Innovation Partners BioBlog. A bipartisan group wishes to delay the health insurance tax by two years. Blue Cross Blue Shield wishes to see ObamaCare subsidies expanded. Meanwhile, consumers aren’t seeing value in value-based care, a finding that surprised researchers. This and more from the world of healthcare in this ...